- Home
- BBNX
as 06-20-2025 4:00pm EST
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | IRVINE |
| Market Cap: | 841.5M | IPO Year: | 2025 |
| Target Price: | $25.20 | AVG Volume (30 days): | 504.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 10 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -5.66 | EPS Growth: | N/A |
| 52 Week Low/High: | $8.89 - $24.50 | Next Earning Date: | 08-06-2025 |
| Revenue: | $69,830,000 | Revenue Growth: | 38911.17% |
| Revenue Growth (this year): | 32.79% | Revenue Growth (next year): | 36.59% |
Latest Beta Bionics Inc. Common Stock News
BBNX Breaking Stock News: Dive into BBNX Ticker-Specific Updates for Smart Investing
GlobeNewswire
a day ago
Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott’s Future Dual Glucose-Ketone Sensor
Investing.com
4 days ago
Truist starts on diabetes device makers, sees glucose monitor, insulin pump growth
MT Newswires
4 days ago
Truist Securities Initiates Beta Bionics at Buy With $26 Price Target
MedTech Dive
19 days ago
Beta Bionics CEO, CFO on how to take a company public
MT Newswires
21 days ago
Goldman Sachs Initiates Coverage on Beta Bionics With Neutral Rating, $16 Price Target
MT Newswires
21 days ago
Wolfe Research Initiates Coverage on Beta Bionics With Outperform Rating, $20 Price Target
MedTech Dive
22 days ago
The medtech IPO window is finally open. Or is it?
GuruFocus.com
a month ago
Beta Bionics Inc (BBNX) Q1 2025 Earnings Call Highlights: Strong Sales Growth and Strategic ...
Compare BBNX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BBNX Beta Bionics Inc. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.